CERO THERAPEUTICS HOLDINGS, INC. financial data

Symbol
CERO, CEROW on OTC
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 19 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 52% % 12%
Debt-to-equity -389% % -433%
Return On Equity 700% % 919%
Return On Assets -242% % -89%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21,102,671 shares -86%
Entity Public Float $5,765,325 USD 114%
Weighted Average Number of Shares Outstanding, Basic 1,264,884 shares 4993%
Weighted Average Number of Shares Outstanding, Diluted 1,264,884 shares 4993%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $8,971,017 USD 46%
General and Administrative Expense $7,161,375 USD -9.9%
Operating Income (Loss) $16,132,392 USD -14%
Nonoperating Income (Expense) $1,424,643 USD -72%
Net Income (Loss) Attributable to Parent $14,707,749 USD -64%
Earnings Per Share, Basic 394 USD/shares 95%
Earnings Per Share, Diluted 394 USD/shares 95%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,900,000 USD
Assets, Current $2,553,899 USD -31%
Property, Plant and Equipment, Net $313,452 USD -50%
Operating Lease, Right-of-Use Asset $869,538 USD -47%
Assets $3,911,394 USD -40%
Accounts Payable, Current $7,077,342 USD 6.2%
Employee-related Liabilities, Current $4,415 USD -91%
Accrued Liabilities, Current $340,691 USD -80%
Liabilities, Current $8,454,556 USD -10%
Operating Lease, Liability, Noncurrent $218,308 USD -80%
Liabilities $8,454,556 USD -17%
Retained Earnings (Accumulated Deficit) $86,297,494 USD -21%
Stockholders' Equity Attributable to Parent $4,543,162 USD -23%
Liabilities and Equity $3,911,394 USD -40%

Popular Metrics

Label TTM Value / Value Unit Change %
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,022,072 USD -40%
Deferred Tax Assets, Valuation Allowance $17,643,000 USD 30%
Deferred Tax Assets, Gross $17,643,000 USD 30%
Operating Lease, Liability $931,023 USD -45%
Depreciation $69,354 USD -39%
Lessee, Operating Lease, Liability, to be Paid $978,809 USD -48%
Property, Plant and Equipment, Gross $2,554,591 USD
Operating Lease, Liability, Current $931,023 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two $726,394 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $726,394 USD -27%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $47,786 USD -74%
Deferred Tax Assets, Operating Loss Carryforwards $12,227,000 USD 35%
Unrecognized Tax Benefits $538,000 USD 17%
Additional Paid in Capital $73,055,709 USD 10%
Share-based Payment Arrangement, Expense $1,241,058 USD -13%
Interest Expense $14,434 USD